J 2023

Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications

BEN-AHARON, Irit, W M VAN LAARHOVEN HANNEKE, Elisa FONTANA, Radka LORDICK OBERMANNOVÁ, Magnus NILSSON et. al.

Basic information

Original name

Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications

Authors

BEN-AHARON, Irit, W M VAN LAARHOVEN HANNEKE, Elisa FONTANA, Radka LORDICK OBERMANNOVÁ (203 Czech Republic, belonging to the institution), Magnus NILSSON and Florian LORDICK

Edition

Cancer Discovery, Philadelphia, American Association for Cancer Research Inc. 2023, 2159-8274

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 28.200 in 2022

RIV identification code

RIV/00216224:14110/23:00133382

Organization unit

Faculty of Medicine

UT WoS

000942506800001

Keywords in English

Gastrointestinal Tract; Early-Onset Cancer

Tags

Tags

International impact, Reviewed
Změněno: 1/2/2024 12:44, Mgr. Tereza Miškechová

Abstract

V originále

Epidemiologic data indicate a significant increase in the incidence of colorectal cancer in younger populations in the past three decades. Moreover, recent evidence also demonstrates a similar trend in gastric, pancreatic, and biliary tract cancers. A majority of these early-onset cases are sporadic and lack hereditary or familial background, implying a potential key role for behavioral, lifestyle, nutritional, microbial, and environmental factors. This review explores the cur-rent data on early-onset gastrointestinal cancer, exploring the etiology, unique treatment considera-tions for this population, future challenges, as well as implications for research and practice. Significance: The worrisome trend of an increasing incidence of early-onset gastrointestinal cancers appears to be correlated with nonhereditary etiologies in which behavioral, lifestyle, nutritional, micro-bial, and environmental factors, as well as host mechanisms, may play a key role. Further epidemiologic and pathogenetic research is urgently needed to better understand the underlying mechanisms and to develop preventive strategies and tailored early detection. Young patients with gastrointestinal cancer face unique challenges and unmet needs. These must be addressed in the future management of the disease to minimize treatment-related somatic morbidity and prevent psychosocial sequelae.